Thank you to our speakers, sponsors, and delegates who joined us in San Francisco for the 2nd Next Generation Ophthalmic Drug Delivery Summit! If you are interested in the 2025 event, please get in touch at

Accelerating Longer Lasting Efficacy & Less Invasive Retinal Drug Delivery to the Clinic

January 30-February 1, 2024 | San Francisco, CA

The Definitive Industry Forum for Longer Lasting & Less Invasive Delivery to the Retina

The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit returned to San Francisco in January to unite 70+ device engineers, biochemists, preclinical and clinical experts as they discussed how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration.

More than 20 expert speakers from the likes of AbbVie, Boehringer Ingelheim, Bayer, Genentech, Janssen, Novartis, and Clearside Biomedical joined the only industry-dedicated event focusing on overcoming key translational challenges of developing and implementing novel delivery technology as they progress their ophthalmic pipelines to the clinic.



Attending Companies Included:

Janssen Iveric Bio Genentech Abbvie and Novartis
OcuTerra, Bayer, Clearside Biomedical, Boehringer Ingelheim, Regeneron
Oculis, Opus Genetics, Nanoscope Therapeutics, Ocugen, Oxular

Wold-Class Speaker Faculty Included:

2024 Partners:

Zero Residual by SJJ Solutions [high res]

Hear Why Your Industry Peers Attended:

“I see tremendous value in participating in events such as the Next Generation Ophthalmic Drug Delivery Summit as it gives us the opportunity to network, be inspired and find areas of potential collaboration with colleagues who are working towards a similar objective of improving sights and improving eye care.”

Riad Sherif, Chief Executive Officer, Oculis


Other Events in the Ophthalmology & Sensory Series: